Allspring Global Investments Holdings LLC Increases Holdings in Chemed Co. (NYSE:CHE)

Allspring Global Investments Holdings LLC boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 143.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 42,267 shares of the company’s stock after buying an additional 24,912 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.28% of Chemed worth $25,401,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. EntryPoint Capital LLC boosted its stake in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after buying an additional 18 shares during the period. Covestor Ltd boosted its stake in Chemed by 10.6% during the first quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after buying an additional 21 shares during the period. GAMMA Investing LLC boosted its stake in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares during the period. Everpar Advisors LLC boosted its stake in Chemed by 4.9% during the second quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after buying an additional 27 shares during the period. Finally, Private Advisor Group LLC boosted its stake in Chemed by 5.9% during the first quarter. Private Advisor Group LLC now owns 592 shares of the company’s stock valued at $380,000 after buying an additional 33 shares during the period. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now directly owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,144 shares of company stock valued at $5,264,839 over the last 90 days. Insiders own 3.32% of the company’s stock.

Chemed Stock Performance

NYSE:CHE opened at $593.15 on Thursday. The stock has a fifty day moving average of $585.24 and a 200 day moving average of $570.10. Chemed Co. has a 52-week low of $502.64 and a 52-week high of $654.62. The firm has a market capitalization of $8.98 billion, a price-to-earnings ratio of 31.92, a P/E/G ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. During the same period last year, the firm earned $4.71 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts forecast that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This represents a $2.00 annualized dividend and a yield of 0.34%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.